Table 2. The treatment modalities of patients with HNSCC and ESCC.
| The patient groups | Surgery ± radio(chemo) therapy | Radio(chemo) and/or target therapy | χ2 | P |
|---|---|---|---|---|
| Treatment of HNSCC | ||||
| Synchronous cancer | 10 (47.6) | 11 (52.4) | ||
| ESCC followed by HNSCC | 9 (60.0) | 6 (40.0) | 0.538 | 0.463 |
| HNSCC followed by ESCC | 27 (79.4) | 7 (20.6) | 5.960 | 0.015 |
| Treatment of ESCC | ||||
| Synchronous cancer | 16 (76.2) | 5 (23.8) | ||
| ESCC followed by HNSCC | 10 (66.7) | 5 (33.3) | 0.396 | 0.529 |
| HNSCC followed by ESCC | 24 (70.6) | 10 (29.4) | 0.205 | 0.650 |
OS, overall survival; HNSCC, squamous cell carcinoma of head and neck; ESCC, squamous cell carcinoma of esophagus.